I have not placed an order with Royal Peptides. This profile is built from a full read of their site and six certificates opened directly on the testing lab's own verification system.
The finding
Royal Peptides publishes 39 certificate links across 31 products, and every one of them points straight at a live record on the testing lab's own server rather than at a PDF or image hosted by the vendor.
That is, structurally, the best certificate presentation of any vendor I have scored. There is no intermediate copy to go stale, no template to mis-fill, and no opportunity to alter a field before publishing. At two other vendors in this field the vendor-hosted copy turned out to differ from the lab's record. Here that failure mode is impossible by design, and Royal deserves real credit for building it that way.
I opened six certificates across six compounds. Here is what the client and manufacturer fields say:
| Compound | Client | Manufacturer | Batch |
|---|---|---|---|
| Retatrutide 10mg | JP | JP | JP20260015 |
| NAD+ 1000 | JP | JP | JP20260012 |
| GHK-Cu 50 | JP | JP | JP20260030 |
| BPC-157 10mg | CHP | Champion Peptide | B26C6H1P0C |
| Tirzepatide 10mg | PEPEtides | PEPEtides | TR10-B26C09 |
| Eloralintide 10mg | PEPEtides | PEPEtides XBT | ELD10 |
Six for six. Three different upstream companies. Royal Peptides appears on none of them, in either field.
To be scrupulous about what this does and does not mean. The testing is real: these are authentic records at live verification URLs, nothing is fabricated, and the analytical results stand. A purity figure of 99.903 percent on the BPC-157 lot is a real measurement of real material.
What the certificates do not evidence is that Royal's inventory was tested. They evidence that JP, Champion Peptide and PEPEtides had batches tested. Whether the vials Royal ships come from those batches is unestablished, and the batch codes on the documents belong to the upstream manufacturers rather than to Royal, which is consistent with resale.
Set against the site's own framing, that gap matters. Banners across the site read "JANOSHIK VERIFIED" and "3RD-PARTY VERIFIED COAS," and the homepage describes "transparent batch reporting." A reader encountering those would reasonably conclude Royal commissioned this testing on their own stock. Nothing on the site says otherwise.
This is why the review carries an integrity flag and lands at Not Recommended regardless of score. Six of six is a strong sample, though not the whole library, and checking the remaining 33 would establish whether any certificate in it is Royal's own. That is the single most valuable follow-up here.
The cGMP claim
A separate banner reads "ROYAL LABS CGMP CDMO QUALITY." That phrase implies an in-house contract development and manufacturing operation running to current good manufacturing practice.
The six certificates name three other manufacturers. No entity called "Royal Labs" could be located anywhere, and no cGMP facility, registration, or certificate number is published on the site. Set beside the certificate finding, the claim reads as describing an operation that the documents do not evidence exists.
What the testing covers
Purity and quantity. That is the whole panel. On the BPC-157 report, the tests requested field reads simply "BPC-157 analysis," and the results table gives two lines: quantity at 10.32 mg and purity at 99.903 percent.
No endotoxin, no sterility, no heavy metals, no residual solvents on any of the six. Several vendors in this field publish four-document packages covering all of those. This is among the narrowest panels here.
What they get genuinely right
Two things, and both deserve to be said clearly.
The Peptide Science Academy is the best educational content any vendor in this field has built. The footer's "Peptide Calculator" link does not go to a dosing tool, as it does at one other vendor here. It redirects to an educational library of more than 100 compound profiles covering molecular identity, proposed mechanisms, biological pathways, research focus, evidence maturity, and literature, plus a sequence explorer. It contains no administration guidance at all. That is a deliberate choice and a good one.
Their brand-protection page names specific impersonating domains. They publish a page identifying royalpeptidesusa.com and royalpeptides.ca as scam domains not affiliated with them, and tell customers to confirm the exact domain before ordering. Given how often lookalike sites distorted the research across this whole batch of vendors, that page is genuinely useful, and those two domains should be kept clear of Royal's own record.
Their research-use labeling is also strong in writing, with a footer that explicitly excludes clinical use, therapeutic purposes, and use on oneself, alongside the standard research-only language. It is pulled the other way by an "Oral" product category and by product URLs written for buyer intent rather than research framing.
Ordering, shipping, and payment
Regional fulfillment across the United States, Canada, and the EU, with order review covering payment, inventory and customer details, tracked delivery where available, and a documented claim review process. Free shipping over $300.
Sales are generally final after processing, with returns and exchanges generally not accepted. Their policy does twice preserve statutory carve-outs, stating that it is subject to rights that cannot lawfully be excluded and that it does not limit any remedy required by applicable consumer law. That is better drafting than most of this field.
Payment methods were not captured, since I stopped short of checkout.
Where they fall short
- Not one certificate in the sample belongs to them. Six opened, three other companies named, Royal on none.
- A cGMP manufacturing claim with no locatable facility.
- The narrowest test panel among vendors publishing certificates at all. Purity and quantity only.
- No address, no legal entity, no named person. Contact is email plus an SMS-only number, and the domain record is fully redacted behind a privacy service. There is no way to establish who operates this business.
- The only sentiment available is self-published. Their Trustpilot profile has been removed, and the replacement is a review archive on their own domain with vendor-applied verification labels and moderated submissions.
Bottom line
The shape here is unusual and worth stating plainly: the documentation infrastructure is the best in this field and the documentation provenance is the worst. Royal built the one certificate system nobody could tamper with, and then filled it with other companies' paperwork.
There may be a perfectly ordinary explanation. Shared upstream supplier, white-label arrangement, distribution deal. Any of those could be true, and if Royal published the relationship the picture would change substantially. What is not acceptable is publishing another company's test reports under "JANOSHIK VERIFIED" banners while saying nothing about whose material was actually tested.
Until that is disclosed, a certificate on this site tells you something true about a batch that may have nothing to do with the vial you receive. Read their Academy, which is excellent and free. Buy the compound somewhere that can show you a test of its own stock.